Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Volitionrx (VNRX) Cost of Revenue (2019 - 2025)

Volitionrx filings provide 7 years of Cost of Revenue readings, the most recent being $1.0 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 19.97% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 26.91% decrease, with the full-year FY2025 number at $3.9 million, down 26.91% from a year prior.
  • Cost of Revenue hit $1.0 million in Q4 2025 for Volitionrx, up from $958567.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $1.9 million in Q4 2023 to a low of $427401.0 in Q1 2021.
  • Median Cost of Revenue over the past 5 years was $1.5 million (2022), compared with a mean of $1.3 million.
  • Biggest five-year swings in Cost of Revenue: soared 436.04% in 2021 and later plummeted 45.16% in 2025.
  • Volitionrx's Cost of Revenue stood at $1.8 million in 2021, then fell by 7.65% to $1.7 million in 2022, then increased by 13.15% to $1.9 million in 2023, then crashed by 34.08% to $1.3 million in 2024, then decreased by 19.97% to $1.0 million in 2025.
  • The last three reported values for Cost of Revenue were $1.0 million (Q4 2025), $958567.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.